Sygnis (Biotechnology) Overview
- Year Founded
-
1997
- Status
-
Out of Business
- Employees
-
20
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
7
- Investments
-
4
Sygnis (Biotechnology) General Information
Description
Developer of biotechnology products designed to replicate DNA. The company is involved in the identification of new polymerases and the development and exploitation of polymerase applications for the sequencing, repair and amplification of DNA and the development of biomarkers for diagnostic and therapeutic uses.
Contact Information
Website
www.sygnis.comCorporate Office
- Waldhofer Street 104
- 69123 Heidelberg
- Germany
Corporate Office
- Waldhofer Street 104
- 69123 Heidelberg
- Germany
Sygnis (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sygnis (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sygnis (Biotechnology) Patents
Sygnis (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201101891-D0 | Method for genotyping | Inactive | 03-Feb-2011 | ||
| ES-2364010-B1 | Mutants of mu polymerase dna | Inactive | 02-Oct-2009 | ||
| ES-2364010-A1 | Mutants of dna polymerase mu | Active | 02-Oct-2009 | C12N9/1252 |
Sygnis (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sygnis (Biotechnology) Acquisitions (4)
Sygnis (Biotechnology)’s most recent deal was a Merger/Acquisition with 4basebio for . The deal was made on 01-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 4basebio | 01-Mar-2018 | Merger/Acquisition | Biotechnology | ||
| C.B.S. Scientific Company | 01-Jan-2017 | Merger/Acquisition | Electrical Equipment | ||
| 2invest | 06-Dec-2012 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Axaron Bioscience | 09-Oct-2006 | Merger/Acquisition | Drug Discovery |
Sygnis (Biotechnology) Exits (1)
Sygnis (Biotechnology)’s most recent exit was on 01-Mar-2018 from 4basebio. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 4basebio | 01-Mar-2018 | Completed |
|
Sygnis (Biotechnology) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 4basebio | Cambridge, United Kingdom | 1997 | |
| C.B.S. Scientific Company | San Diego, CA | 1973 |
Sygnis (Biotechnology) FAQs
-
When was Sygnis (Biotechnology) founded?
Sygnis (Biotechnology) was founded in 1997.
-
Where is Sygnis (Biotechnology) headquartered?
Sygnis (Biotechnology) is headquartered in Heidelberg, Germany.
-
What is the size of Sygnis (Biotechnology)?
Sygnis (Biotechnology) has 20 total employees.
-
What industry is Sygnis (Biotechnology) in?
Sygnis (Biotechnology)’s primary industry is Biotechnology.
-
Is Sygnis (Biotechnology) a private or public company?
Sygnis (Biotechnology) is a Private company.
-
What is Sygnis (Biotechnology)’s current revenue?
The current revenue for Sygnis (Biotechnology) is .
-
How much funding has Sygnis (Biotechnology) raised over time?
Sygnis (Biotechnology) has raised $49.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
